Description

PT-141 (Bremelanotide Acetate)

PT-141 (scientifically identified as Bremelanotide Acetate) is a high-purity synthetic peptide derivative of Melanotan II. In the domains of neurobiology and sexual medicine research, PT-141 is classified as a non-selective melanocortin receptor agonist. Unlike traditional phosphodiesterase-5 (PDE5) inhibitors that act directly on the vascular system, PT-141 is designed to exert its effects primarily through the central nervous system. Its primary research focus involves the activation of melanocortin receptors (specifically MC3R and MC4R) within the hypothalamus to modulate biological pathways associated with arousal and physiological response. PT-141 provides researchers with a sophisticated experimental tool to investigate the neuroendocrine mechanisms of sexual dysfunction and the systemic regulation of appetitive behavior.

Research Applications & Mechanisms

Central Nervous System Modulation

Neuroendocrine Signaling & Pathways

Management of Hypoactive Sexual Desire (HSDD)

Systemic Homeostasis & Receptor Affinity

Technical Specifications

Key Features & Quality Assurance

• Pharmaceutical-Grade Lyophilization: Our proprietary vacuum-sealing and freeze-drying process ensures the powder surface is perfectly smooth, flat, and delicate. This uniform “cake” structure guarantees rapid reconstitution and protects the peptide from degradation.

• ISO 9001 Quality Management: Every production cycle follows a rigorous quality management system to ensure that the chemical identity of every batch is precisely as specified.

• GMP Compliance: Manufactured in a sterile, clean-room environment to eliminate cross-contamination, providing the batch-to-batch consistency essential for reproducible research.

• Verified Stability: The cyclic structure of our Bremelanotide Acetate is optimized for maximum stability and receptor binding affinity.

Reconstitution Guide (Important)

To ensure the maximum stability and integrity of the peptide, please follow these laboratory guidelines:

• Preparation: Allow the vial to reach room temperature before reconstitution. Center the vial in a centrifuge for 30-60 seconds to ensure the lyophilized cake is at the bottom.

• Solvent Selection: Reconstitute with Sterile Water for Injection or Bacteriostatic Water (0.9% Benzyl Alcohol).

• Technique: Gently inject the diluent along the side of the vial wall. DO NOT SHAKE the vial; instead, gently swirl it until the solution is clear and colorless.

• Concentration: We recommend a standard research concentration of 10mg/mL.

Storage & Handling

• Long-term: Store at -20°C (Maintains potency for up to 24 months).

• Short-term: Stable at 2–8°C for up to 3 months.

• Reconstitution: We recommend centering the vial in a centrifuge before opening. Reconstitute using sterile or bacteriostatic water. The high-solubility lyophilized powder should yield a clear, colorless solution in seconds.

Shipping & Documentation

• Global Logistics: Shipped in temperature-controlled, discrete packaging to ensure privacy and product security.

• Verified Quality: A batch-specific Certificate of Analysis (COA), including HPLC and Mass Spectrometry (MS) reports, is available for every order.

• Reshipment Policy: We provide a guaranteed reshipment policy for any lost or customs-intercepted orders (terms apply).

⚠️ Research Disclaimer

For Laboratory Research and Analytical Purposes Only. PT-141 is NOT a drug, food, or cosmetic and is strictly not intended for human or veterinary consumption. Handling and use must be performed by qualified laboratory professionals in accordance with standard safety protocols.

Scientific Resources & References

• PubChem Database: Detailed Chemical Profile of Bremelanotide

• Co-administration of low doses of intranasal PT–141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response

🔍 Deep Dive Research

Expand your laboratory protocols with our technical insights:

• [Technical Guide]:

• [Comparative Study]:

• [Quality Standards]: